Grafa News and Videos — Page 382

Diatreme Resources (ASX:DRX) announced that joint venture partner Sibelco Silica has injected an additional $4.4 million into their silica sand project.

Anthropic plans to buy 1.4 gigawatts of Australian data centre capacity costing $21.6 billion to build.

Telstra (ASX:TLS) experienced a nationwide mobile network outage from approximately 3:00 am on July 8.

Macquarie Group (ASX:MQG) investors are set to challenge the board over the integrity of the selection process that appointed KPMG as its new auditor.

Large-scale wind projects are seeking alternative funding from the NSW Electricity Infrastructure Roadmap.

Vera Therapeutics (NASDAQ:VERA) received United States FDA accelerated approval for TRUTAKNA (atacicept-vymj) to reduce proteinuria in adults with primary IgA nephropathy at risk of rapid disease progression.

SkinHealth Systems (NASDAQ:SKIN) received new United States Food and Drug Administration clearance for its specialized SkinStylus SteriLock MicroSystem to improve the appearance of periorbital wrinkles in adult patients.

Axsome Therapeutics (NASDAQ:AXSM) announced it dosed the first patient in its Phase 3 FOCUS-2 clinical trial evaluating solriamfetol as a potential treatment for children with attention deficit hyperactivity disorder.

Amazon.com (NASDAQ:AMZN) is looking to raise at least $25 billion through a U.S. dollar bond sale, according to Bloomberg News, as the company continues funding AI infrastructure investments.

Tvardi Therapeutics (NASDAQ:TVRD) reported Phase 1 data for TTI-109, a phosphate prodrug of STAT3 inhibitor TTI-101, including up to 60% reductions in STAT3-driven Th17, Tfh, and B cell populations.